Compugroup Medical (ETR:COP) received a €52.00 ($61.90) price objective from research analysts at Baader Bank in a report issued on Tuesday. The brokerage presently has a “neutral” rating on the stock. Baader Bank’s price objective points to a potential downside of 6.83% from the company’s current price.

COP has been the subject of several other reports. Deutsche Bank set a €60.00 ($71.43) target price on Compugroup Medical and gave the company a “buy” rating in a research report on Monday, October 16th. Warburg Research set a €56.00 ($66.67) target price on Compugroup Medical and gave the company a “buy” rating in a research report on Thursday, December 14th. Berenberg Bank set a €53.00 ($63.10) target price on Compugroup Medical and gave the company a “neutral” rating in a research report on Monday, October 16th. Commerzbank set a €62.00 ($73.81) target price on Compugroup Medical and gave the company a “buy” rating in a research report on Monday, November 13th. Finally, set a €61.00 ($72.62) target price on Compugroup Medical and gave the company a “buy” rating in a research report on Wednesday, October 18th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of €58.17 ($69.25).

Compugroup Medical (ETR COP) opened at €55.81 ($66.44) on Tuesday. Compugroup Medical has a 1 year low of €36.12 ($43.00) and a 1 year high of €57.70 ($68.69).

TRADEMARK VIOLATION NOTICE: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/12/21/compugroup-medical-cop-given-a-52-00-price-target-by-baader-bank-analysts.html.

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physicianÂ’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Stock Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related stocks with our FREE daily email newsletter.